Indeed, MT-DUX4-ASO could effectively decrease the expression of DUX4 target genes and improve the reduced myogenic differentiation in in vitro FSHD myotubes, even without transfection reagents, which suggests the high potency of MT-DUX4-ASO. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.